text: <unk>  refers to a two-week regimen consisting of rituximab,cyclophosphamide, doxorubicin (hydroxydaunorubicin, vincristine (Oncovin), etoposide, and prednisone used to treat diffuse large B-cell lymphoma.
option_0: R-CHOEP-14 regimen
option_1: ICE-R regimen
option_2: R-CDOP regimen
option_3: FLAMSA-MEL regimen
option_4: FMC-R regimen
option_5: MINE-R regimen
option_6: ProMACE-MOPP regimen
option_7: DHAX-R regimen